УЛЬТРАЗВУКОВОЕ КАРТИРОВАНИЕ И РАДИОЧАСТОТНАЯ АБЛАЦИЯ СУБСТРАТА ЖЕЛУДОЧКОВЫХ ТАХИКАРДИЙ У КАНДИДАТА НА ТРАНСПЛАНТАЦИЮ СЕРДЦА С ЭЛЕКТРИЧЕСКИМ ШТОРМОМ

Приводится клиническое наблюдение ультразвукового картирования и радиочастотной катетерной аблации субстрата желудочковых тахикардий у пациента с дилятационной кардиомиопатией и электрическим штормом

дилятационная кардиомиопатия, желудочковая тахикардия, фибрилляция желудочков, электрический шторм, имплантируемый кардиовертер-дефибриллятор, ультразвуковое картирование, радиочастотная катетерная аблация

1. Bardy G.H., Lee K.L., Mark D.B. et al. Sudden Cardiac Death in Heart Failure Trial I. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure // N Engl J Med 2005; 352: 225-237.

2. Calkins H., Epstein A., Packer D. et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group // J Am Coll Cardiol 2000; 35: 1905-1914.

3. Carbucicchio C., Santamaria M., Trevisi N. et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study // Circulation 2008; 117: 462-469.

4. Cesario D.A., Vaseghi M., Boyle N.G. et al. Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia // Heart Rhythm. 2006; 3: 1-10.

5. Cheng A., Nguyen T.C., Malinowski M. et al. Undersized mitral annuloplasty inhibits left ventricular basal wall thickening but does not affect equatorial wall cardiac strains // J Heart Valve Dis 2007; 16(4): 349-58.

6. Cheng A., Nguyen T.C., Malinowski M., et al. Effects of undersized mitral annuloplasty on regional transmural left ventricular wall strains and wall thickening mechanisms // Circulation 2006; 114(1 Suppl): I600-9.

7. Connolly S.J., Dorian P., Roberts R.S. et al. Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients I. Comparison of beta-blockers, amiodarone plus betablockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial // J Am Med Assoc 2006; 295: 165-171.

8. Connolly S.J., Hallstrom A.P., Cappato R. et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiar-rhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study // Eur Heart J 2000; 21: 2071-2078.

9. Deneke T., Shin D.I., Lawo T., et al. Catheter ablation of electrical storm in a collaborative hospital network // Am J Cardiol 2011; 108: 233-239.

10. Hsia H.H., Callans D.J., Marchlinski F.E. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation. 2003; 108: 704-710.

11. Kamphuis H.C., de Leeuw J.R., Derksen R. et al. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study // Europace 2003; 5: 381-389.

12. Kozeluhova M., Peichl P., Cihak R. et al. Catheter ablation of electrical storm in patients with structural heart disease // Europace 2011; 13: 109-113.

13. Kuck K.H., Schaumann A., Eckardt L. et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial // Lancet 2010; 375: 31-40.

14. Nakahara S., Tung R., Ramirez R.J. et al. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia // J Am Coll Cardiol 2010; 55: 2355-2365.

15. Nazarian S., Bluemke D.A., Lardo A.C. et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy // Circulation. 2005; 112: 2821-2825.

16. Poole J.E., Johnson G.W., Hellkamp A.S. et al. Prognostic importance of defibrillator shocks in patients with heart failure // N Engl J Med 2008; 359: 1009-1017.

17. Reddy V.Y., Reynolds M.R., Neuzil P. et al. Prophylactic catheter ablation for the prevention of defibrillator therapy // N Engl J Med 2007; 357: 2657-2665.

18. Soejima K., Stevenson W.G., Sapp J.L. et al. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars // J Am Coll Cardiol. 2004; 43: 1834 -1842.

19. Stevenson W.G., Wilber D.J., Natale A. et al. Multicenter Thermocool VTATI. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial // Circulation 2008; 118: 2773-2782.

20. Tanner H., Hindricks G., Volkmer M. et al. Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study // J Cardiovasc Electrophysiol 2010; 21: 47-53.

21. Wissner E., Stevenson W.G., Kuck K.-H. Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review // European Heart Journal (2012) 33, 1440-1450.